Action 600713 NANJING PHARMACEUTICAL COMPANY LIMITED
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues NanJing Pharmaceutical Company Limited

Actions

600713

CNE000000KV1

Cours en clôture Shanghai S.E.
Autres places de cotation
 00:00:00 01/07/2024 		Varia. 5j. Varia. 1 janv.
4,33 CNY +2,61% Graphique intraday de NanJing Pharmaceutical Company Limited -1,59% -10,54%
28/05 Nanjing Pharmaceutical émet des obligations à ultra-court terme pour un montant de 500 millions de yuans MT
29/04 NanJing Pharmaceutical Company Limited présente ses résultats pour le premier trimestre clos le 31 mars 2024 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Nanjing Pharmaceutical Issues 500 Million Yuan Ultra-Short-Term Bonds
NanJing Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024
NanJing Medical Plans to Issue Up to 6 Billion Yuan in Ultra Short-Term Bonds
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2023
NanJing Pharmaceutical Company Limited(XSSC:600713) added to S&P Global BMI Index
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Half Year Ended June 30, 2023
NanJing Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022
NanJing Pharmaceutical Company Limited entered into Framework Agreement to acquire 55% stake in Suzhou Tianqing Xingwei Pharmaceutical Co., Ltd., a 55% stake in Zhejiang Tianqing Zhongwei Pharmaceutical Co., Ltd., and a 100% of Lianyungang Chia Tai-Tianqing Pharmaceutical Co., Ltd.
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2022
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Half Year Ended June 30, 2022
NanJing Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2022
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2021
NanJing Medical’s Controlling Shareholder Boosts Stake to 44.2% For $158 Million
NanJing Pharmaceutical Company Limited announced that it has received CNY 997.999997 million in funding from Nanjing XinGong Investment Group Co., Ltd
Sichuan Luyan Pharmaceutical Co., Ltd. agreed to acquire Sichuan Yatong Pharmaceutical Co., Ltd. from NanJing Pharmaceutical Company Limited for CNY 19.9 million.
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2021
NanJing Pharmaceutical Company Limited announced that it expects to receive CNY 999.999998 million in funding from Nanjing XinGong Investment Group Co., Ltd
Nanjing Pharmaceutical Company Limited Reports Earnings Results for the Half Year Ended June 30, 2021
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 600713
  4. Actualités NanJing Pharmaceutical Company Limited
  5. Autres langues